| Clinical data | |
|---|---|
| Trade names | Tolinase |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682482 |
| License data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | metabolized in the liver to active metabolites |
| Eliminationhalf-life | 7 hours |
| Excretion | Renal (85%) and fecal (7%) |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.013.262 |
| Chemical and physical data | |
| Formula | C14H21N3O3S |
| Molar mass | 311.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Tolazamide is anoralblood glucose loweringdrug used for people withType 2 diabetes. It is part of thesulfonylurea family (ATC A10BB).

The reaction between p-toluenesulfonamide (1) andethyl chloroformate (2) in the presence of base gives tosylurethane [5577-13-9] (3). Heating that intermediate withazepane (4) leads to the displacement of the ethoxy group and the formation oftolazemide (5).[1][2][3][4][5]
Azepane proper would lead to [13078-23-4].
Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |